TAKAHISA KOIDE: Open Payments
NPI 1508514456 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$199 in 10 payments from 8 companies in 2025. Trend: 2023 $117 · 2024 $223 · 2025 $199
Food & beverage: $199
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $37 |
| Novo Nordisk Inc | 2 | $34 |
| Amgen Inc. | 2 | $32 |
| Exact Sciences Corporation | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Boston Scientific Corporation | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
Products named: TRINTELLIX, The Cologuard Plus Collection Kit, JARDIANCE, TRELEGY ELLIPTA, Wegovy, OTEZLA, General - Pain Management, REPATHA.
Industry payments across ID — which companies pay providers there.
